Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-02-20 @ 6:41 PM
Study NCT ID:
NCT00988169
Status:
TERMINATED
Last Update Posted:
2015-11-20
First Post:
2009-09-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-30
First Submit QC Date:
None
Study First Post Date:
2009-10-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-19
Results First Submit QC Date:
None
Results First Post Date:
2015-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-10-19
Last Update Post Date:
2015-11-20
Last Update Post Date Type:
ESTIMATED